Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Glendale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) compared with placebo in participants with moderately to severely active ulcerative colitis (UC).
Sponsor: Hoffmann-La Roche
Check if you qualify for this ulcerative colitis clinical trial in Glendale, AZ
If you're searching for ulcerative colitis treatment options in Glendale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.